Patients with celiac disease who take an angiotensin receptor blocker (ARB) may experience worse outcomes, such as iron ...

A new federal petition has been launched, and calls for a $1,000 refundable tax credit for people with celiac disease, like ...

In the fourth quarter of 2024, we expect to announce updated data from the VTP-300 program in ongoing clinical trials in chronic hepatitis B at AASLD – The Liver Meeting® 2024 scheduled from November ...

Celiac disease is a digestive and immune disorder that can keep the body from absorbing necessary nutrients. "Our conception and awareness of celiac disease has evolved over the past few decades, but ...

In 2025, children within the TEDDY study will submit their final samples at research clinics in Sweden, Finland, Germany and ...

In 2025, children within the TEDDY study will submit their final samples at research clinics in Sweden, Finland, Germany and the United States. The international study has provided a lot of new ...

If you feel sick or uncomfortable after eating foods like bread or pasta, you're not alone. Millions of people struggle with ...

Many people find that wheat or gluten cause them to react in some way: Some people have a wheat allergy, some have the ...

According to various data, 1.0–10.4% of children diagnosed with DM1 develop celiac disease—the data vary according to age and diagnostic methods (2). In Northern Poland, celiac disease was ...

HAMBURG, Germany I October 15, 2024 I Topas Therapeutics today announced positive topline results from its Phase 2a trial evaluating lead candidate, TPM502, in patients with celiac disease. The study ...

Topas Therapeutics has hailed a win for its immune-tolerance platform, reporting positive phase 2a data on its celiac disease candidate without sharing numbers to validate its upbeat outlook.

The thing is: BMI is a metric that was not designed to diagnose someone with a disease, posing a significant problem for the medical community, as well as contributing to stigma for people with ...